PTD‑DBM is a cell‑penetrating peptide that the small community has tried for hair follicle regeneration, with the lone report noting a positive outcome but low confidence, according to the limited community data. Users typically describe a dose of about 2 mg per day, though most posts do not specify a timing or cycling schedule, reflecting the community modal of 2 mg/day with unspecified timing and cycling. The primary tradeoff to note is that PTD‑DBM carries no FDA‑approved indication, meaning all human use is off‑label or compounded.
Data last updated
Measured on 2 of 6 axes
Evidence shape
According to the site’s data, PTD‑DBM has an evidence tier of none because zero human published studies have been recorded. Consequently, no indications have been mapped, no trials are registered, and the breadth and quality sections both show zero entries, indicating an absence of any completed human research. This lack of human data means there is no posted trial signal—no efficacy, safety, or dosage information—to guide judgments about the peptide’s use.
Human evidence
No human study rows have been captured for this peptide yet.
Lower-tier support
No animal or in-vitro support rows have been captured yet.
Published literature
The research corpus was searched; no standalone peptide-level publications were indexed beyond the trials and preclinical rows above.
Source data
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Symptom-relevant clinical or community evidence has not been captured for this peptide yet.
price offers can be sorted by column · 1 out-of-stock offer not shown
How PTD-DBM is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
No structured protocol details captured for this tier yet.
The only community anecdote cites a 2 mg subcutaneous dose of PTD‑DBM, without specifying how often it is taken or any cycling regimen.